- Illustrations
- Specialized Illustrations
- Progression of Fetal Growth at Week 17 Excluding the Placenta
Progression of Fetal Growth at Week 17 Excluding the Placenta
A closer profile of the fetus at Gestational Week Seventeen comes into focus, outlining the elongation of the neck.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Presented in lateral profile, a 17 week human fetus (conceptus excluding the placenta) lies in a flexed fetal posture with the cervical region lengthening between the occiput and upper thorax. The cranial vault remains proportionally prominent relative to the trunk, while the upper limbs are adducted with the elbows and wrists flexed so the hands rest near the anterior chest. Lower limbs sit in hip and knee flexion, bringing the thighs toward the abdomen and the legs toward the posterior pelvis, with the spine forming a gentle C shaped curvature. Week 17 sits in the transition from embryology to clinically relevant fetal anatomy, when crown rump length, head to body proportion, and limb posture are commonly referenced in obstetric assessment. A true placenta excluded rendering keeps attention on fetal morphology rather than placental location, which helps when correlating developmental milestones with ultrasound biometry and with common screening findings such as nuchal fold measurement and early recognition of limb reduction patterns. Neck elongation is a teachable landmark here, because it changes the apparent relationship of mandible, thorax, and upper limb position across the second trimester. Use this asset in embryology and human development courses, obstetric counseling materials, and figure panels for textbooks or review articles discussing gestational age estimation around 16 to 18 weeks and normal fetal posture in utero. It also fits patient education sheets that contrast fetal and placental components without conflating them. Anatomical accuracy verified by SciePro's Medical Advisory Board.